Results 41 to 50 of about 5,029 (156)

Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences

open access: yesBiologics: Targets & Therapy, 2008
Matthew L Stoll, Alisa C GotteDepartment of Pediatrics, Division of Rheumatology, UT Southwestern Medical Center, Dallas, TX, USAAbstract: Biologics have advanced the therapy of adult and pediatric arthritis. They have been linked to rare serious adverse
Matthew L Stoll, Alisa C Gotte
doaj   +1 more source

Data-Driven Magnetic Resonance Imaging Definitions for Active and Structural Sacroiliac Joint Lesions in Juvenile Spondyloarthritis Typical of Axial Disease: A Cross-Sectional International Study. [PDF]

open access: yesArthritis Care Res (Hoboken), 2023
ObjectiveWe aimed to determine quantitative sacroiliac (SI) joint magnetic resonance imaging (MRI) cutoffs for active and structural lesions that will be incorporated as imaging domains in classification criteria of axial disease in juvenile ...
Weiss PF   +11 more
europepmc   +2 more sources

Advances in the Diagnosis and Treatment of Enthesitis-Related Arthritis

open access: yesChildren, 2023
Enthesitis-related arthritis (ERA) represents 5–30% of all cases of juvenile idiopathic arthritis (JIA) and belongs to the spectrum of the disorders included in the group of juvenile spondyloarthritis.
Simona Di Gennaro   +7 more
doaj   +1 more source

Common incidental findings on sacroiliac joint MRI in children clinically suspected of juvenile spondyloarthritis. [PDF]

open access: yesEur J Radiol Open, 2020
PURPOSE: To determine the prevalence of incidental findings on sacroiliac (SI) joint MRI in children clinically suspected of Juvenile Spondyloarthritis (JSpA).
Schiettecatte E   +7 more
europepmc   +2 more sources

Whole-Body MRI in Rheumatology: Major Advances and Future Perspectives

open access: yesDiagnostics, 2021
Whole-body magnetic resonance imaging is constantly gaining more importance in rheumatology, particularly for what concerns the diagnosis, follow-up, and treatment response evaluation. Initially applied principally for the study of ankylosing spondylitis,
Luca Deplano   +8 more
doaj   +1 more source

How to Treat Patients after Serious Adverse Effects Caused by TNF Inhibitors?

open access: yesActa Clinica Croatica, 2020
Biological agents are widely used in the treatment of autoimmune rheumatic disorders. We report on serious adverse events during treatment with anti-tumor necrosis factor antibody in two of our patients with juvenile idiopathic arthritis. One patient was
Saša Sršen   +5 more
doaj   +1 more source

The Increased Levels of Fecal Calprotectin in Children With Active Enthesitis Related Arthritis and MRI Signs of Sacroiliitis: The Results of a Single Center Cross-Sectional Exploratory Study in Juvenile Idiopathic Arthritis Patients

open access: yesFrontiers in Medicine, 2021
Enthesitis related arthritis (ERA) is a specific subtype of juvenile idiopathic arthritis (JIA), often regarded as an undifferentiated form of juvenile spondyloarthritis (jSpA). While gut is increasingly recognized as origin and/or target of inflammation
Lovro Lamot   +9 more
doaj   +1 more source

РОЛЬ РАННЕЙ ЛУЧЕВОЙ ДИАГНОСТИКИ САКРОИЛЕИТОВ У ДЕТЕЙ ПРИ СИНДРОМЕ АРТРИТА

open access: yes, 2020
The term juvenile spondyloarthritis (JSpA) refers to spondyloarthritis that starts during childhood. Juvenile spondyloarthropathy (JSpA) represents an important subgroup of chronic arthritis in children that needs to be recognized and appropriately ...
А. А. Карпенко, A. K. Karpenko
core   +2 more sources

Juvenile Spondyloarthritis

open access: yes, 2011
Juvenile ...
Miroslav Harjacek   +4 more
openaire   +3 more sources

Survey of current practices in the management of anti-TNF failure in juvenile spondyloarthritis

open access: yes, 2022
OBJECTIVES: To evaluate the current practices in management of patients with juvenile spondyloarthritis (JSpA) who failed anti-tumour necrosis factor agents (anti-TNF).
Weiss, Pamela F   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy